Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Localized Prostate Cancer”

219 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 219 results

Early research (Phase 1)Looking for participantsNCT07054346
What this trial is testing

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Who this might be right for
Prostate CancerProstate Cancer (Diagnosis)High-risk Prostate Cancer+2 more
Thomas Hope 45
Not applicableLooking for participantsNCT06178354
What this trial is testing

Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer

Who this might be right for
Localized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+2 more
University of California, Davis 100
Testing effectiveness (Phase 2)UnknownNCT05249712
What this trial is testing

Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Very early researchStudy completedNCT02420977
What this trial is testing

Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Large-scale testing (Phase 3)Active Not RecruitingNCT02799706
What this trial is testing

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 885
Testing effectiveness (Phase 2)Looking for participantsNCT04812366
What this trial is testing

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of British Columbia 315
Not applicableStudy completedNCT00789607
What this trial is testing

Fiducial Localization and Individualized Radiotherapy -Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 17
Not applicableActive Not RecruitingNCT03312972
What this trial is testing

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

Who this might be right for
Locally Recurrent Prostate Cancer
Loyola University 50
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Not applicableUnknownNCT04239599
What this trial is testing

Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 178
Testing effectiveness (Phase 2)Looking for participantsNCT07455903
What this trial is testing

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Baptist Health South Florida 50
Testing effectiveness (Phase 2)UnknownNCT05376722
What this trial is testing

Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer

Who this might be right for
Neoadjuvant Therapy
Hongqian Guo 30
Not applicableLooking for participantsNCT07115992
What this trial is testing

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%

Who this might be right for
Prostate CancerProstate Adenoma
Ruijin Hospital 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT04253483
What this trial is testing

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+2 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableUnknownNCT03632980
What this trial is testing

Dynamic Focusing Evaluation for Prostate Cancer Treatment

Who this might be right for
Cancer of Prostate
EDAP TMS S.A. 180
Testing effectiveness (Phase 2)Ended earlyNCT01704027
What this trial is testing

Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Centre Georges Francois Leclerc 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923180
What this trial is testing

Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Testing effectiveness (Phase 2)Looking for participantsNCT07182279
What this trial is testing

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
The Methodist Hospital Research Institute 29
Large-scale testing (Phase 3)Ended earlyNCT00651326
What this trial is testing

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 48
Next Page